Overview
AI-enabled antibody discovery for therapeutic development.
Details
AbCellera (Nasdaq: ABCL) discovers therapeutic antibodies using high-throughput microfluidics and ML. Partnerships with Lilly (incl. bamlanivimab), Pfizer, and Regeneron.
Tags
antibody-discovery, biologics, ml, public-company, canada